Table of Contents Executive Summary 1 Industry Overview of Neurological Disorder Drugs 1.1 Definition of Neurological Disorder Drugs 1.2 Neurological Disorder Drugs Segment by Type 1.2.1 Global Neurological Disorder Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Antipsychotic 1.2.3 Hypnotic & Sedative 1.2.4 Analgesics 1.2.5 Anticoagulants 1.2.6 Others 1.3 Neurological Disorder Drugs Segment by Applications 1.3.1 Global Neurological Disorder Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.4 Global Neurological Disorder Drugs Overall Market 1.4.1 Global Neurological Disorder Drugs Revenue (2014-2025) 1.4.2 Global Neurological Disorder Drugs Production (2014-2025) 1.4.3 North America Neurological Disorder Drugs Status and Prospect (2014-2025) 1.4.4 Europe Neurological Disorder Drugs Status and Prospect (2014-2025) 1.4.5 China Neurological Disorder Drugs Status and Prospect (2014-2025) 1.4.6 Japan Neurological Disorder Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Neurological Disorder Drugs Status and Prospect (2014-2025) 1.4.8 India Neurological Disorder Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Neurological Disorder Drugs 2.3 Manufacturing Process Analysis of Neurological Disorder Drugs 2.4 Industry Chain Structure of Neurological Disorder Drugs 3 Development and Manufacturing Plants Analysis of Neurological Disorder Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Neurological Disorder Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Neurological Disorder Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Neurological Disorder Drugs Production and Capacity Analysis 4.2 Neurological Disorder Drugs Revenue Analysis 4.3 Neurological Disorder Drugs Price Analysis 4.4 Market Concentration Degree 5 Neurological Disorder Drugs Regional Market Analysis 5.1 Neurological Disorder Drugs Production by Regions 5.1.1 Global Neurological Disorder Drugs Production by Regions 5.1.2 Global Neurological Disorder Drugs Revenue by Regions 5.2 Neurological Disorder Drugs Consumption by Regions 5.3 North America Neurological Disorder Drugs Market Analysis 5.3.1 North America Neurological Disorder Drugs Production 5.3.2 North America Neurological Disorder Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Neurological Disorder Drugs Import and Export 5.4 Europe Neurological Disorder Drugs Market Analysis 5.4.1 Europe Neurological Disorder Drugs Production 5.4.2 Europe Neurological Disorder Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Neurological Disorder Drugs Import and Export 5.5 China Neurological Disorder Drugs Market Analysis 5.5.1 China Neurological Disorder Drugs Production 5.5.2 China Neurological Disorder Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Neurological Disorder Drugs Import and Export 5.6 Japan Neurological Disorder Drugs Market Analysis 5.6.1 Japan Neurological Disorder Drugs Production 5.6.2 Japan Neurological Disorder Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Neurological Disorder Drugs Import and Export 5.7 Southeast Asia Neurological Disorder Drugs Market Analysis 5.7.1 Southeast Asia Neurological Disorder Drugs Production 5.7.2 Southeast Asia Neurological Disorder Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Neurological Disorder Drugs Import and Export 5.8 India Neurological Disorder Drugs Market Analysis 5.8.1 India Neurological Disorder Drugs Production 5.8.2 India Neurological Disorder Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Neurological Disorder Drugs Import and Export 6 Neurological Disorder Drugs Segment Market Analysis (by Type) 6.1 Global Neurological Disorder Drugs Production by Type 6.2 Global Neurological Disorder Drugs Revenue by Type 6.3 Neurological Disorder Drugs Price by Type 7 Neurological Disorder Drugs Segment Market Analysis (by Application) 7.1 Global Neurological Disorder Drugs Consumption by Application 7.2 Global Neurological Disorder Drugs Consumption Market Share by Application (2014-2019) 8 Neurological Disorder Drugs Major Manufacturers Analysis 8.1 Novartis AG 8.1.1 Novartis AG Neurological Disorder Drugs Production Sites and Area Served 8.1.2 Novartis AG Product Introduction, Application and Specification 8.1.3 Novartis AG Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 GlaxoSmithKline plc 8.2.1 GlaxoSmithKline plc Neurological Disorder Drugs Production Sites and Area Served 8.2.2 GlaxoSmithKline plc Product Introduction, Application and Specification 8.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Merck & Co. 8.3.1 Merck & Co. Neurological Disorder Drugs Production Sites and Area Served 8.3.2 Merck & Co. Product Introduction, Application and Specification 8.3.3 Merck & Co. Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Bayer AG 8.4.1 Bayer AG Neurological Disorder Drugs Production Sites and Area Served 8.4.2 Bayer AG Product Introduction, Application and Specification 8.4.3 Bayer AG Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 AstraZeneca 8.5.1 AstraZeneca Neurological Disorder Drugs Production Sites and Area Served 8.5.2 AstraZeneca Product Introduction, Application and Specification 8.5.3 AstraZeneca Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Boehringer Ingelheim GmbH 8.6.1 Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Sites and Area Served 8.6.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification 8.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Teva Pharmaceutical 8.7.1 Teva Pharmaceutical Neurological Disorder Drugs Production Sites and Area Served 8.7.2 Teva Pharmaceutical Product Introduction, Application and Specification 8.7.3 Teva Pharmaceutical Neurological Disorder Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 9 Development Trend of Analysis of Neurological Disorder Drugs Market 9.1 Global Neurological Disorder Drugs Market Trend Analysis 9.1.1 Global Neurological Disorder Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Neurological Disorder Drugs Regional Market Trend 9.2.1 North America Neurological Disorder Drugs Forecast 2019-2025 9.2.2 Europe Neurological Disorder Drugs Forecast 2019-2025 9.2.3 China Neurological Disorder Drugs Forecast 2019-2025 9.2.4 Japan Neurological Disorder Drugs Forecast 2019-2025 9.2.5 Southeast Asia Neurological Disorder Drugs Forecast 2019-2025 9.2.6 India Neurological Disorder Drugs Forecast 2019-2025 9.3 Neurological Disorder Drugs Market Trend (Product Type) 9.4 Neurological Disorder Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Neurological Disorder Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Neurological Disorder Drugs Table Global Neurological Disorder Drugs Production (K Units) Growth Rate Comparison by Types (2014-2025) Figure Global Neurological Disorder Drugs Production Market Share by Types in 2018 Figure Antipsychotic Product Picture Figure Hypnotic & Sedative Product Picture Figure Analgesics Product Picture Figure Anticoagulants Product Picture Figure Others Product Picture Table Global Neurological Disorder Drugs Consumption (K Units) Comparison by Applications (2014-2025) Figure Global Neurological Disorder Drugs Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Global Neurological Disorder Drugs Revenue (Million USD) (2014-2025) Figure Global Neurological Disorder Drugs Production (K Units) (2014-2025) Figure North America Neurological Disorder Drugs Market Size (Million USD) (2014-2025) Figure Europe Neurological Disorder Drugs Market Size (Million USD) (2014-2025) Figure China Neurological Disorder Drugs Market Size (Million USD) (2014-2025) Figure Japan Neurological Disorder Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Neurological Disorder Drugs Market Size (Million USD) (2014-2025) Figure India Neurological Disorder Drugs Market Size (Million USD) (2014-2025) Table Neurological Disorder Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Neurological Disorder Drugs in 2018 Figure Manufacturing Process Analysis of Neurological Disorder Drugs Figure Industry Chain Structure of Neurological Disorder Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Neurological Disorder Drugs Manufacturing Plants Distribution Table Neurological Disorder Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Neurological Disorder Drugs Capacity (K Units) of Major Manufacturers (2014-2019) Table Neurological Disorder Drugs Production (K Units) of Major Manufacturers (2014-2019) Table Neurological Disorder Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Neurological Disorder Drugs Production Share by Manufacturers in 2018 Table Neurological Disorder Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Neurological Disorder Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Neurological Disorder Drugs Revenue Share by Manufacturers in 2018 Table Neurological Disorder Drugs Average Price (USD/Unit) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Neurological Disorder Drugs Production by Regions 2014-2019 (K Units) Table Global Neurological Disorder Drugs Production Market Share by Regions 2014-2019 Figure Global Neurological Disorder Drugs Production Market Share by Regions in 2018 Table Global Neurological Disorder Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Neurological Disorder Drugs Revenue Market Share by Regions 2014-2019 Figure Global Neurological Disorder Drugs Revenue Market Share by Regions in 2018 Table Global Neurological Disorder Drugs Consumption by Regions 2014-2019 (K Units) Table Global Neurological Disorder Drugs Consumption Market Share by Regions 2014-2019 Figure North America Neurological Disorder Drugs Production Growth Rate 2014-2019 (K Units) Figure North America Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Neurological Disorder Drugs Production, Consumption Import and Export (K Units) Figure Europe Neurological Disorder Drugs Production Growth Rate 2014-2019 (K Units) Figure Europe Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Neurological Disorder Drugs Production, Consumption Import and Export (K Units) Figure China Neurological Disorder Drugs Production Growth Rate 2014-2019 (K Units) Figure China Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Neurological Disorder Drugs Production, Consumption Import and Export (K Units) Figure Japan Neurological Disorder Drugs Production Growth Rate 2014-2019 (K Units) Figure Japan Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Neurological Disorder Drugs Production, Consumption Import and Export (K Units) Figure Southeast Asia Neurological Disorder Drugs Production Growth Rate 2014-2019 (K Units) Figure Southeast Asia Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Neurological Disorder Drugs Production, Consumption Import and Export (K Units) Figure India Neurological Disorder Drugs Production Growth Rate 2014-2019 (K Units) Figure India Neurological Disorder Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Neurological Disorder Drugs Production, Consumption Import and Export (K Units) Figure Global Consumption Neurological Disorder Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Neurological Disorder Drugs Market Share by Application (2014-2019) Table Novartis AG Neurological Disorder Drugs Production Sites and Area Served Table Novartis AG Neurological Disorder Drugs Product Introduction, Application and Specification Table Novartis AG Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Novartis AG Neurological Disorder Drugs Production Growth Rate (2014-2019) Table Novartis AG Neurological Disorder Drugs Production Market Share (2014-2019) Figure Novartis AG Neurological Disorder Drugs Revenue Market Share (2014-2019) Table Novartis AG Neurological Disorder Drugs Main Business and Markets Served Table GlaxoSmithKline plc Neurological Disorder Drugs Production Sites and Area Served Table GlaxoSmithKline plc Neurological Disorder Drugs Product Introduction, Application and Specification Table GlaxoSmithKline plc Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table GlaxoSmithKline plc Neurological Disorder Drugs Production Growth Rate (2014-2019) Table GlaxoSmithKline plc Neurological Disorder Drugs Production Market Share (2014-2019) Figure GlaxoSmithKline plc Neurological Disorder Drugs Revenue Market Share (2014-2019) Table GlaxoSmithKline plc Neurological Disorder Drugs Main Business and Markets Served Table Merck & Co. Neurological Disorder Drugs Production Sites and Area Served Table Merck & Co. Neurological Disorder Drugs Product Introduction, Application and Specification Table Merck & Co. Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Merck & Co. Neurological Disorder Drugs Production Growth Rate (2014-2019) Table Merck & Co. Neurological Disorder Drugs Production Market Share (2014-2019) Figure Merck & Co. Neurological Disorder Drugs Revenue Market Share (2014-2019) Table Merck & Co. Neurological Disorder Drugs Main Business and Markets Served Table Bayer AG Neurological Disorder Drugs Production Sites and Area Served Table Bayer AG Neurological Disorder Drugs Product Introduction, Application and Specification Table Bayer AG Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Bayer AG Neurological Disorder Drugs Production Growth Rate (2014-2019) Table Bayer AG Neurological Disorder Drugs Production Market Share (2014-2019) Figure Bayer AG Neurological Disorder Drugs Revenue Market Share (2014-2019) Table Bayer AG Neurological Disorder Drugs Main Business and Markets Served Table AstraZeneca Neurological Disorder Drugs Production Sites and Area Served Table AstraZeneca Neurological Disorder Drugs Product Introduction, Application and Specification Table AstraZeneca Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table AstraZeneca Neurological Disorder Drugs Production Growth Rate (2014-2019) Table AstraZeneca Neurological Disorder Drugs Production Market Share (2014-2019) Figure AstraZeneca Neurological Disorder Drugs Revenue Market Share (2014-2019) Table AstraZeneca Neurological Disorder Drugs Main Business and Markets Served Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Sites and Area Served Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Product Introduction, Application and Specification Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Growth Rate (2014-2019) Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Market Share (2014-2019) Figure Boehringer Ingelheim GmbH Neurological Disorder Drugs Revenue Market Share (2014-2019) Table Boehringer Ingelheim GmbH Neurological Disorder Drugs Main Business and Markets Served Table Teva Pharmaceutical Neurological Disorder Drugs Production Sites and Area Served Table Teva Pharmaceutical Neurological Disorder Drugs Product Introduction, Application and Specification Table Teva Pharmaceutical Neurological Disorder Drugs Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019) Table Teva Pharmaceutical Neurological Disorder Drugs Production Growth Rate (2014-2019) Table Teva Pharmaceutical Neurological Disorder Drugs Production Market Share (2014-2019) Figure Teva Pharmaceutical Neurological Disorder Drugs Revenue Market Share (2014-2019) Table Teva Pharmaceutical Neurological Disorder Drugs Main Business and Markets Served Figure Global Neurological Disorder Drugs Production (K Units) Growth Rate Forecast 2019-2025 Figure Global Neurological Disorder Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Neurological Disorder Drugs Sales Price (USD/Unit) Forecast 2019-2025 Figure North America Neurological Disorder Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure North America Neurological Disorder Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Neurological Disorder Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Europe Neurological Disorder Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Neurological Disorder Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure China Neurological Disorder Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Neurological Disorder Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Japan Neurological Disorder Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Neurological Disorder Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure Southeast Asia Neurological Disorder Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Neurological Disorder Drugs Production Growth Rate Forecast 2019-2025 (K Units) Figure India Neurological Disorder Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Units) of Neurological Disorder Drugs by Type (2019-2025) Table Global Consumption (K Units) of Neurological Disorder Drugs by Application (2019-2025) Table Neurological Disorder Drugs Distributors List Table Neurological Disorder Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis AG GlaxoSmithKline plc Merck & Co. Bayer AG AstraZeneca Boehringer Ingelheim GmbH Teva Pharmaceutical